Syntax Advisors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $231K | Buy |
899
+157
| +21% | +$40.4K | 0.2% | 138 |
|
|
2023
Q2 | $211K | Sell |
742
-193
| -21% | -$55K | 0.17% | 185 |
|
|
2023
Q1 | $260K | Buy |
935
+89
| +11% | +$24.7K | 0.2% | 130 |
|
|
2022
Q4 | $234K | Sell |
846
-362
| -30% | -$100K | 0.2% | 148 |
|
|
2022
Q3 | $323K | Sell |
1,208
-10
| -0.8% | -$2.67K | 0.28% | 61 |
|
|
2022
Q2 | $248K | Buy |
1,218
+58
| +5% | +$11.8K | 0.21% | 126 |
|
|
2022
Q1 | $244K | Buy |
1,160
+42
| +4% | +$8.83K | 0.2% | 152 |
|
|
2021
Q4 | $268K | Buy |
+1,118
| New | +$268K | 0.2% | 155 |
|